MBXCX
Price
$36.62
Change
+$0.08 (+0.22%)
Updated
Jun 5 closing price
Net Assets
8.03B
MBXIX
Price
$38.05
Change
+$0.08 (+0.21%)
Updated
Jun 5 closing price
Net Assets
8.03B
Interact to see
Advertisement

MBXCX vs MBXIX

Header iconMBXCX vs MBXIX Comparison
Open Charts MBXCX vs MBXIXBanner chart's image
Catalyst/Millburn Hedge Strategy C
Price$36.62
Change+$0.08 (+0.22%)
VolumeN/A
Net Assets8.03B
Catalyst/Millburn Hedge Strategy I
Price$38.05
Change+$0.08 (+0.21%)
VolumeN/A
Net Assets8.03B
MBXCX vs MBXIX Comparison Chart
Loading...
View a ticker or compare two or three
VS
MBXCX vs. MBXIX commentary
Jun 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MBXCX is a Buy and MBXIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
MBXCX (8.03B) and MBXIX (8.03B) have equal amount of cash in the bank . MBXIX pays higher dividends than MBXCX: MBXIX (1.92) vs MBXCX (0.97). MBXCX was incepted earlier than MBXIX: MBXCX (9 years) vs MBXIX (9 years). MBXCX (3.03) is less costly to investors than MBXIX (2.03). MBXCX (48.00) and MBXIX (48.00) have comparable annual turnover. MBXCX (2500) and MBXIX (2500) have matching initial minimum investment requirements. MBXIX annual gain was more profitable for investors over the last year : -0.99 vs. MBXCX (-1.98). MBXIX return over 5 years is better than : 52.64 vs. MBXCX (44.99).
MBXCXMBXIXMBXCX / MBXIX
Total Expense Ratio3.032.03149%
Annual Report Gross Expense Ratio3.032.03149%
Fund Existence9 years9 years-
Gain YTD-2.586-2.190118%
Front LoadN/AN/A-
Min. Initial Investment25002500100%
Min. Initial Investment IRAN/AN/A-
Net Assets8.03B8.03B100%
Annual Yield % from dividends0.971.9251%
Returns for 1 year-1.98-0.99200%
Returns for 3 years4.547.8758%
Returns for 5 years44.9952.6485%
Returns for 10 yearsN/AN/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SHPAX18.99N/A
N/A
Saratoga Health & Biotechnology A
GSMGX13.59N/A
N/A
Goldman Sachs Small/Mid Cap Growth C
JLCYX69.59N/A
N/A
JHancock Fundamental Large Cap Core R2
BPIRX14.18N/A
N/A
Boston Partners Long/Short Rsrch Instl
REQCX41.54-0.09
-0.22%
Russell Sustnbl Aware Eq C